BioSpace News Archive

Deals

Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain

Flexion Therapeutics, Inc. and Xenon Pharmaceuticals Inc. announced that the companies have entered into a definitive agreement that provides Flexion with the global rights to develop and commercialize XEN402, a NaV1.7 inhibitor, for the management of post-operative pain.

September 10, 2019
·
6 min read
Business

RHYTHM AI Successfully Closes Seed Financing Round

Proceeds to fund multi-centre study of STAR Mapping to improve outcomes of persistent Atrial Fibrillation treatment

September 10, 2019
·
2 min read
Business

Imvax Appoints John P. Furey as Chief Executive Officer

Former Chief Operating Officer of Spark Therapeutics brings 25 years of global biopharmaceutical experience

September 10, 2019
·
3 min read
BerGenBio to Present at H.C. Wainwright 21st Annual Global Life Sciences Conference

BerGenBio ASA announces that Richard Godfrey, BergenBio’s chief executive officer, will present at the H.C. Wainwright 21st Annual Global Life Sciences Conference today, September 10, 2019.

September 10, 2019
·
2 min read
EveliQure’s diarrhoea vaccine to advance towards clinical trials supported by a significant Horizon2020 award

EveliQure Biotechnologies announces the award of a grant from Horizon2020 - the European Union´s Research and Innovation programme - that supports first-in-man studies of its proprietary ShigETEC vaccine.

September 10, 2019
·
4 min read
Business

CuraSen Therapeutics Expands Management Team; Appoints Peter Butera as Senior Vice President, Operations

CuraSen Therapeutics, Inc., a privately held clinical stage biotechnology company focused on developing therapies to treat neurodegenerative diseases, has appointed Peter Butera as senior vice president, operations

September 10, 2019
·
3 min read
Bio NC

MindPath Care Centers Sponsoring Annual Foundation of Hope Charity Dinner and Auction

Committed to community involvement to help increase access to mindcare and raise awareness of addiction recovery for North Carolina residents

September 10, 2019
·
3 min read
Business

Varian-equipped New York Proton Therapy Center Treats First Patients

NYPC is expected to treat 1,400 patients annually, including most children in New York City with solid tumors, delivering the most advanced form of cancer radiation treatment currently available.

September 10, 2019
·
3 min read
Biotech Bay

Karuna Labs Secures $3 Million in Seed Funding; Hires Top Medical and Tech Talent to Further Treatment of Chronic Pain with VR

The company has recently added industry experts from the medical and gaming industries to its team, including Dr. James Petros, Chief Medical Officer, and Andy Riedel, Chief Technology Officer.

September 10, 2019
·
2 min read
Cannamedical® Pharma Successfully Imports the First Medicinal Cannabis From Portugal to Germany, Representing the Largest-ever Shipment of Medicinal Cannabis From an EU Country to Germany

On September 9th, Cannamedical® Pharma GmbH, a leading cannabis distributor and one of the best-known medicinal cannabis brands in Germany and the European Union, imported from Portugal to Germany, the largest quantity of medicinal cannabis ever transported within the European Union.

September 10, 2019
·
3 min read